Atlas Trials

Safety of Stopping Pancreatic Enzyme Replacement Therapy in Children With Improved Pancreatic Function After Highly Effective Modulator Therapy

Clinical trial NCT07632768 · COMPLETED

Trial details

NCT number
NCT07632768
Sponsor
Indiana University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cystic Fibrosis (CF)Pancreatic InsufficiencyPancreas DiseaseExocrine Pancreatic InsufficiencyExocrine Pancreatic Insufficiency in Subjects With Cystic FibrosisCFTR Gene Mutation
Start date
2024-12-03
Primary completion
2026-01-21
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.